EVOLUS, INC. Increase (Decrease) in Inventories
EVOLUS, INC. (EOLS) reported Increase (Decrease) in Inventories of -$5.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-05
- EVOLUS, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $1.33M, a 84.05% decline year-over-year.
- EVOLUS, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$6.38M.
- EVOLUS, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$4.66M.
- EVOLUS, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was $11.49M, a 678.59% increase year-over-year.
- EVOLUS, INC. increase (decrease) in inventories for fiscal 2025 was $11.12M.
- EVOLUS, INC. increase (decrease) in inventories for fiscal 2024 was -$3.25M.
- EVOLUS, INC. increase (decrease) in inventories for fiscal 2023 was -$4.19M, a 139.23% decline from fiscal 2022.
- EVOLUS, INC. increase (decrease) in inventories for fiscal 2022 was $10.69M, a 258.78% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$5.05M 10-Q · filed 2026-08-05 | -$9.71M derived: sum of 3 quarters · filed 2026-08-05 | $1.78M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$6.38M 10-Q · filed 2026-05-04 | -$11.04M derived: sum of 2 quarters · filed 2026-05-04 | $455.00K derived: sum of 3 quarters · filed 2026-05-04 | $8.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $6.83M derived: sum of 2 quarters · filed 2026-03-03 | $15.17M derived: sum of 3 quarters · filed 2026-08-05 | $11.12M 10-K · filed 2026-03-03 |
| 2025-09-30 | $11.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $19.83M derived: sum of 2 quarters · filed 2026-08-05 | $15.78M 10-Q · filed 2025-11-05 | $14.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $8.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $4.29M 10-Q · filed 2026-08-05 | $3.31M derived: sum of 3 quarters · filed 2026-08-05 | $4.79M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$4.05M 10-Q · filed 2026-05-04 | -$5.03M derived: sum of 2 quarters · filed 2026-05-04 | -$3.55M derived: sum of 3 quarters · filed 2026-05-04 | -$1.99M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$979.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $497.00K derived: sum of 2 quarters · filed 2026-03-03 | $2.06M derived: sum of 3 quarters · filed 2026-03-03 | -$3.25M 10-K · filed 2026-03-03 |
| 2024-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.04M derived: sum of 2 quarters · filed 2025-11-05 | -$2.27M 10-Q · filed 2025-11-05 | -$7.12M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$3.75M 10-Q · filed 2025-08-05 | -$8.60M derived: sum of 3 quarters · filed 2026-03-03 | -$13.55M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | -$5.31M 10-Q · filed 2025-05-07 | -$10.16M derived: sum of 2 quarters · filed 2026-03-03 | -$15.11M derived: sum of 3 quarters · filed 2026-03-03 | -$15.96M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | -$4.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$9.80M derived: sum of 2 quarters · filed 2026-03-03 | -$10.65M derived: sum of 3 quarters · filed 2026-03-03 | -$4.19M 10-K · filed 2026-03-03 |
| 2023-09-30 | -$4.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$5.80M derived: sum of 2 quarters · filed 2024-11-06 | $654.00K 10-Q · filed 2024-11-06 | -$3.94M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | -$848.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $5.61M 10-Q · filed 2024-07-31 | $1.01M derived: sum of 3 quarters · filed 2025-03-04 | $3.67M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $6.46M 10-Q · filed 2024-05-07 | $1.86M derived: sum of 2 quarters · filed 2025-03-04 | $4.52M derived: sum of 3 quarters · filed 2025-03-04 | $11.57M derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | -$4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$1.94M derived: sum of 2 quarters · filed 2025-03-04 | $5.12M derived: sum of 3 quarters · filed 2025-03-04 | $10.69M 10-K · filed 2025-03-04 |
| 2022-09-30 | $2.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $9.71M derived: sum of 2 quarters · filed 2023-11-07 | $15.28M 10-Q · filed 2023-11-07 | $11.10M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $7.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $12.63M 10-Q · filed 2023-08-02 | $8.44M derived: sum of 3 quarters · filed 2023-08-02 | $15.62M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $5.57M 10-Q · filed 2023-05-09 | $1.39M derived: sum of 2 quarters · filed 2023-05-09 | $8.57M derived: sum of 3 quarters · filed 2023-05-09 | $11.70M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $3.00M derived: sum of 2 quarters · filed 2023-03-08 | $6.13M derived: sum of 3 quarters · filed 2023-03-08 | $2.98M 10-K · filed 2023-03-08 |
| 2021-09-30 | $7.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $10.31M derived: sum of 2 quarters · filed 2022-11-08 | $7.16M 10-Q · filed 2022-11-08 | $4.16M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $3.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$20.00K 10-Q · filed 2022-08-02 | -$3.03M derived: sum of 3 quarters · filed 2022-08-02 | -$4.29M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | -$3.15M 10-Q · filed 2022-05-10 | -$6.16M derived: sum of 2 quarters · filed 2022-05-10 | -$7.42M derived: sum of 3 quarters · filed 2022-05-10 | -$9.62M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$4.27M derived: sum of 2 quarters · filed 2022-03-03 | -$6.47M derived: sum of 3 quarters · filed 2022-03-03 | -$4.54M 10-K · filed 2022-03-03 |
| 2020-09-30 | -$1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$3.46M derived: sum of 2 quarters · filed 2021-11-02 | -$1.54M 10-Q · filed 2021-11-02 | -$3.28M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | -$2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$270.00K 10-Q · filed 2021-08-04 | -$2.01M derived: sum of 3 quarters · filed 2021-08-04 | -$7.31M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $1.93M 10-Q · filed 2021-05-12 | $186.00K derived: sum of 2 quarters · filed 2021-05-12 | -$5.11M derived: sum of 3 quarters · filed 2021-05-12 | $3.83M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$7.04M derived: sum of 2 quarters · filed 2021-03-25 | $1.90M derived: sum of 3 quarters · filed 2021-03-25 | $4.48M 10-K · filed 2021-03-25 |
| 2019-09-30 | -$5.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $3.65M derived: sum of 2 quarters · filed 2020-10-29 | $6.22M 10-Q · filed 2020-10-29 | $6.22M derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-06-30 | $8.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $11.52M 10-Q · filed 2020-08-10 | $11.52M derived: sum of 3 quarters · filed 2020-08-10 | $11.52M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $2.58M 10-Q · filed 2020-05-11 | $2.58M derived: sum of 2 quarters · filed 2020-05-11 | $2.58M derived: sum of 3 quarters · filed 2020-05-11 | $2.58M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $0.00 10-K · filed 2020-02-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $0.00 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $0.00 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |